High Throughput Screening

CNS Drug discovery Genetics

Fast Gene Target Validation & Drug Screening All In One

Harness the potential of our new Zebrafish-Based Platform for High-Throughput Gene Target Validation and Drug Screening in F0

Toxicology Zebrafish model organism

Zebrafish larvae as a New Alternative Methodology (NAM) for the assessment of compounds’ teratogenicity

Combining a zebrafish-based high throughput platform with artificial intelligence for human developmental toxicity assessment.

AI-in-drug-Discovery Drug discovery

How Artificial Intelligence Can Unlock Cures for Current and Future Diseases?

AI can address many challenges and limitations in traditional R&D and offer value in drug discovery in multiple ways.

In-vivo-epilepsy-research CNS Drug discovery

Fishing for innovative alternatives for modeling epilepsy

Why zebrafish can pave the way for investigating epilepsy’s etiology and screening new anti-seizure drugs

zebrafish-larvae Toxicology Zebrafish model organism

How Automation and Optimization Help us do Better Science

In ZeClinics we bet on emerging technologies to scale our solutions.

screening-toxicity-with-zebrafish Toxicology

Dozens of Compounds with Unknown Toxicity Profiles in your Hands: Why Entrust the Screening to Zebrafish?

From challenge to knowledge: the outstanding performance of zebrafish in predicting toxicity.

Larvae zebrafish at ZeClinics CNS Drug discovery Genetics Metabolics Ophthalmology Toxicology Zebrafish model organism

R&D: What does ZeClinics do?

ZeClinics laboratory R&D efforts are mainly divided in the development of three research platforms including a number of research areas.